HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?

Abstract
Long-term consequences of cortisol excess are frequent despite appropriate treatment after cure of Cushing's syndrome. This might be due to diagnostic delay, often difficult to reduce in rare diseases. The identification of a genetic predisposing factor might help to improve early diagnosis by familial screening. Primary bilateral macronodular adrenal hyperplasia (PBMAH) is a rare cause of Cushing's syndrome. Hypercortisolism in PBMAH is most often diagnosed between the fifth and sixth decades of life. The bilateral nature of the adrenocortical tumors and the occurrence of rare clear familial forms suggest a genetic origin. Indeed, a limited subset of PBMAH can be observed as part of multiple tumors syndromes due to alterations of the APC, Menin or Fumarate Hydratase genes. Rare variants of the phosphodiesterases PDE11A have been associated with PBMAH. The recent identification of ARMC5 germline alterations in 25-50% of PBMAH patients without obvious familial history or associated tumors opens new perspectives. ARMC5 alterations follow the model of a tumor suppressor gene: a first germline inactivating mutation of this 16p located gene is followed by a somatic secondary hit on the other allele (inactivating mutation or allelic loss). Functional studies demonstrate that ARMC5 controls apoptosis and steroid synthesis. The phenotype of index cases patients with the mutation seems more severe than the one of WT index cases. However, phenotype variability within a family is often observed. This review summarizes the genetics of PBMAH, focusing on ARMC5, which offer new perspectives for early diagnosis of Cushing's syndrome.
AuthorsLudivine Drougat, Stéphanie Espiard, Jerôme Bertherat
JournalEuropean journal of endocrinology (Eur J Endocrinol) Vol. 173 Issue 4 Pg. M121-31 (Oct 2015) ISSN: 1479-683X [Electronic] England
PMID26264719 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© 2015 European Society of Endocrinology.
Chemical References
  • ARMC5 protein, human
  • Armadillo Domain Proteins
  • MEN1 protein, human
  • Proto-Oncogene Proteins
  • Tumor Suppressor Proteins
  • Phosphoric Diester Hydrolases
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • PDE11A protein, human
  • Fumarate Hydratase
Topics
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Armadillo Domain Proteins
  • Cushing Syndrome (diagnosis, genetics)
  • Early Diagnosis
  • Fumarate Hydratase (genetics)
  • Genes, APC
  • Germ-Line Mutation
  • Humans
  • Mutation
  • Phosphoric Diester Hydrolases (genetics)
  • Proto-Oncogene Proteins (genetics)
  • Tumor Suppressor Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: